Lim Shern Kwok, Khoo Boon Yin
Institute for Research in Molecular Medicine, Universiti Sains Malaysia, 11800 Penang, Malaysia.
Oncol Lett. 2021 Nov;22(5):785. doi: 10.3892/ol.2021.13046. Epub 2021 Sep 14.
There has been increased interest in using stem cells for regenerative medicine and cancer therapy in the past decade. Mesenchymal stem cells (MSCs) are among the most studied stem cells due to their unique characteristics, such as self-renewal and developmental potency to differentiate into numerous cell types. MSC use has fewer ethical challenges compared with other types of stem cells. Although a number of studies have reported the beneficial effects of MSC-based therapies in treating various diseases, their contribution to cancer therapy remains controversial. The behaviour of MSCs is determined by the interaction between intrinsic transcriptional genes and extrinsic environmental factors. Numerous studies continue to emerge, as there is no denying the potential of MSCs to treat a wide variety of human afflictions. Therefore, the present review article provided an overview of MSCs and their differences compared with embryonic stem cells, and described the molecular mechanisms involved in maintaining their stemness. In addition, the article examined the therapeutic application of stem cells in the field of cancer. The present article also discussed the current divergent roles of MSCs in cancer therapy and the future potential in this field.
在过去十年中,人们对使用干细胞进行再生医学和癌症治疗的兴趣与日俱增。间充质干细胞(MSCs)因其独特的特性,如自我更新能力和分化为多种细胞类型的发育潜能,成为研究最多的干细胞之一。与其他类型的干细胞相比,使用MSCs面临的伦理挑战较少。尽管许多研究报告了基于MSCs的疗法在治疗各种疾病方面的有益效果,但其在癌症治疗中的作用仍存在争议。MSCs的行为由内在转录基因与外在环境因素之间的相互作用决定。由于不可否认MSCs在治疗多种人类疾病方面的潜力,众多研究不断涌现。因此,本综述文章概述了MSCs及其与胚胎干细胞的差异,并描述了维持其干性所涉及的分子机制。此外,文章还探讨了干细胞在癌症领域的治疗应用。本文还讨论了MSCs目前在癌症治疗中存在的不同作用以及该领域的未来潜力。